FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008889136> ?p ?o ?g. }

• W2008889136 endingPage "576" @default.
• W2008889136 startingPage "559" @default.
• W2008889136 abstract "The December 2003 report from the National Institute of Neurological Disorders and Stroke (NINDS) Workshop on priorities for clinical research in intracerebral hemorrhage (ICH) recommended clinical trials for evaluation of blood pressure management in acute ICH as a leading priority. The Special Writing Group of the Stroke Council of the American Heart Association in 1999 and 2007 emphasized the need for clinical trials to ensure evidence-based treatment of acute hypertensive response in ICH. To address important gaps in knowledge, we conducted a pilot study funded by the NINDS, Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) I Trial, during 2004-2008 to determine the appropriate level of systolic blood pressure (SBP) reduction. We now have initiated a multi-center, randomized Phase III trial, the ATACH II Trial, to definitively determine the efficacy of early, intensive, antihypertensive treatment using intravenous (IV) nicardipine initiated within 3 h of onset of ICH and continued for the next 24 h in subjects with spontaneous supratentorial ICH. The primary hypothesis of this large (N = 1,280), streamlined, and focused trial is that SBP reduction to ≤140 mm Hg reduces the likelihood of death or disability at 3 months after ICH, defined by modified Rankin scale score of 4-6, by at least 10% absolute compared to standard SBP reduction to ≤180 mm Hg. The ATACH II trial is a natural extension of numerous case series, the subsequent ATACH I pilot trial, and a preliminary, randomized, and controlled trial in this patient population funded by the Australian National Health and Medical Research Council. Both trials recently confirmed the safety and tolerability of both the regimen and goals of antihypertensive treatment in acutely hypertensive patients with ICH, as proposed in the present trial. The underlying mechanism for this expected beneficial effect of intensive treatment is presumably mediated through reduction of the rate and magnitude of hematoma expansion observed in approximately 73% of the patients with acute ICH. The Australian trial provided preliminary evidence of attenuation of hematoma expansion with intensive SBP reduction. The ATACH II trial will have important public health implications by providing evidence of, or lack thereof, regarding the efficacy and safety of acute antihypertensive treatment in subjects with ICH. This treatment represents a strategy that can be made widely available without the need for specialized equipment and personnel, and therefore, can make a major impact upon clinical practice for treating patients with ICH." @default.
• W2008889136 created "2016-06-24" @default.
• W2008889136 creator A5002815959 @default.
• W2008889136 creator A5036895407 @default.
• W2008889136 date "2011-05-28" @default.
• W2008889136 modified "2023-10-14" @default.
• W2008889136 title "Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: Design, Methods, and Rationale" @default.
• W2008889136 cites W132472807 @default.
• W2008889136 cites W142034419 @default.
• W2008889136 cites W151371462 @default.
• W2008889136 cites W1592471891 @default.
• W2008889136 cites W1947113872 @default.
• W2008889136 cites W1965069494 @default.
• W2008889136 cites W1967442413 @default.
• W2008889136 cites W1969661146 @default.
• W2008889136 cites W1972014835 @default.
• W2008889136 cites W1978759574 @default.
• W2008889136 cites W1979041225 @default.
• W2008889136 cites W1981194197 @default.
• W2008889136 cites W1982248652 @default.
• W2008889136 cites W1996843574 @default.
• W2008889136 cites W2000616430 @default.
• W2008889136 cites W2002251042 @default.
• W2008889136 cites W2012796013 @default.
• W2008889136 cites W2015098925 @default.
• W2008889136 cites W2016013569 @default.
• W2008889136 cites W2021327381 @default.
• W2008889136 cites W2021648195 @default.
• W2008889136 cites W2023676419 @default.
• W2008889136 cites W2024151167 @default.
• W2008889136 cites W2030988272 @default.
• W2008889136 cites W2039415880 @default.
• W2008889136 cites W2045663952 @default.
• W2008889136 cites W2048087380 @default.
• W2008889136 cites W2050683802 @default.
• W2008889136 cites W2050878470 @default.
• W2008889136 cites W2052174547 @default.
• W2008889136 cites W2052461540 @default.
• W2008889136 cites W2053568672 @default.
• W2008889136 cites W2054097361 @default.
• W2008889136 cites W2055639649 @default.
• W2008889136 cites W2056136317 @default.
• W2008889136 cites W2056244223 @default.
• W2008889136 cites W2058384458 @default.
• W2008889136 cites W2059928130 @default.
• W2008889136 cites W2060832182 @default.
• W2008889136 cites W2061214350 @default.
• W2008889136 cites W2061570300 @default.
• W2008889136 cites W2062503141 @default.
• W2008889136 cites W2070507194 @default.
• W2008889136 cites W207375174 @default.
• W2008889136 cites W2074578101 @default.
• W2008889136 cites W2077861519 @default.
• W2008889136 cites W2084062287 @default.
• W2008889136 cites W2084869945 @default.
• W2008889136 cites W2089876925 @default.
• W2008889136 cites W2094585602 @default.
• W2008889136 cites W2099457690 @default.
• W2008889136 cites W2099706007 @default.
• W2008889136 cites W2107752063 @default.
• W2008889136 cites W2108012929 @default.
• W2008889136 cites W2109305097 @default.
• W2008889136 cites W2111329151 @default.
• W2008889136 cites W2111421663 @default.
• W2008889136 cites W2112040973 @default.
• W2008889136 cites W2118328144 @default.
• W2008889136 cites W2121451738 @default.
• W2008889136 cites W2127707745 @default.
• W2008889136 cites W2136112013 @default.
• W2008889136 cites W2138013284 @default.
• W2008889136 cites W2139780687 @default.
• W2008889136 cites W2142640478 @default.
• W2008889136 cites W2142848477 @default.
• W2008889136 cites W2146307187 @default.
• W2008889136 cites W2155074770 @default.
• W2008889136 cites W2156589326 @default.
• W2008889136 cites W2157724112 @default.
• W2008889136 cites W2164400108 @default.
• W2008889136 cites W2165843498 @default.
• W2008889136 cites W2312959997 @default.
• W2008889136 cites W2330235342 @default.
• W2008889136 cites W2399155639 @default.
• W2008889136 cites W2466287378 @default.
• W2008889136 cites W2548934243 @default.
• W2008889136 cites W2760460727 @default.
• W2008889136 cites W4238103798 @default.
• W2008889136 doi "https://doi.org/10.1007/s12028-011-9538-3" @default.
• W2008889136 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3340125" @default.
• W2008889136 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21626077" @default.
• W2008889136 hasPublicationYear "2011" @default.
• W2008889136 type Work @default.
• W2008889136 sameAs 2008889136 @default.
• W2008889136 citedByCount "187" @default.
• W2008889136 countsByYear W20088891362012 @default.
• W2008889136 countsByYear W20088891362013 @default.
• W2008889136 countsByYear W20088891362014 @default.
• W2008889136 countsByYear W20088891362015 @default.
• W2008889136 countsByYear W20088891362016 @default.

• next